Actualidad

/
/
Masimo Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Masimo Reports Fourth Quarter and Fiscal Year 2016 Financial Results

14/02/2017

Q4 2016 Highlights (compared to Q4 2015):

Total revenue, including royalties, rose 9.5% to $183.2 million

Product revenue rose 10.0% to $175.7 million

Masimo rainbow® revenue declined 11.6% to $16.9 million

48,600 SET® and rainbow SET™ oximeters were
shipped

Net income of $215.3 million, or $3.97 per diluted share versus $24.1
million, or $0.46 per diluted share, in the year-ago period

FY 2016 Highlights (compared to FY 2015):

Total revenue, including royalties, rose 10.2% to $694.6 million

Más información: Masimo Reports Fourth Quarter and Fiscal Year 2016 Financial Results

Comparte:

El contenido de este sitio web está destinado únicamente a profesionales médicos/sanitarios.

Es posible que los productos contenidos en este sitio no estén disponibles en todos los mercados, ya que la disponibilidad está sujeta a prácticas normativas y médicas en mercados individuales.